AM21-06: Oral Abstract Session -- Blood Donation

Learning Objectives:

• Identify prediction models for hemoglobin deferral or low-iron donation to tailor inter-donation intervals to minimize donor risk and deferral for at risk donors
• Evaluate the effectiveness of identifying and encouraging treatment of low iron states in donors through the use of prior and subsequent ferritin and hemoglobin testing, return rates and return donation intervals
• Compare and contrast risk factors for HIV infection in blood donors during two time periods: 2015-2020 and 2010-2013
• Review effectiveness of DHQ questions for ART, PrEP/PEP to estimate under-reporting of high-risk situations in donors

Moderator(s):

• Eric Senaldi, MD, New York Blood Center
• Dawn Ward, Division of Transfusion Medicine, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA

Speaker(s):

• W. Alton Russell, PhD, Stanford University
• Dr. Ralph R. Vassallo, MD, Executive Vice President, Chief Medical & Scientific Officer, Vitalant Corporate Medical Affairs
• Roberta Bruhn, MS, PhD, Co - Director, Vitalant Research Institute
• Brian Custer, PhD. MPH, Vitalant Research Institute

Disclosures

• Dawn Ward:
  Nothing to Disclose
• Eric Senaldi, MD:
  Nothing to Disclose